Delisted from the US markets in May 2023
IBA - Industrias Bachoco, S.A.B. de C.V.
NYSE
->
Consumer Defensive
->
Farm Products
Celaya,
Mexico
Type: Equity
IBA price evolution
IBA
| (in millions $) | 31 Jan 2023 | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20391.69 | $20479.8 | $20114.03 | |
| Short term investments | ||||
| Net receivables | $5944.68 | $5048.4 | $6321.53 | |
| Inventory | $9477.07 | $13156.5 | $6977.23 | |
| Total current assets | $40987.24 | $40305.4 | $36661.53 | |
| Long term investments | ||||
| Property, plant & equipment | $24028.53 | $22816.9 | $22853.46 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $72043.53 | $70429.6 | $66175.82 | |
| Current liabilities | ||||
| Accounts payable | $6001.64 | $6460.3 | $8299.43 | |
| Deferred revenue | ||||
| Short long term debt | $1502.22 | $1500.86 | ||
| Total current liabilities | $9632.21 | $11948.6 | $10911.4 | |
| Long term debt | $2996.47 | $434.36 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $18862.25 | $18193.6 | $15979.16 | |
| Shareholders' equity | ||||
| Retained earnings | $50179.38 | $49207.3 | $47165.06 | |
| Other shareholder equity | $983.85 | $1000.9 | $986.79 | |
| Total shareholder equity | $52751.18 | $51796.2 | $49739.8 | |
| (in millions $) | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 | 30 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $20707.11 | $17286.37 | $18662.76 | $17901.85 |
| Short term investments | $1559.82 | $937.72 | $315.76 | |
| Net receivables | $5475.68 | $4366.7 | $3880.78 | $3486.45 |
| Inventory | $6370.66 | $6301.53 | $5338.49 | $5280.16 |
| Total current assets | $37970.49 | $32586.01 | $31097.25 | $29775 |
| Long term investments | ||||
| Property, plant & equipment | $22336.12 | $20412.67 | $19379.38 | $18018.18 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1214.19 | $1279.47 | $1203.02 | |
| Total investments | ||||
| Total assets | $65934.8 | $58475 | $55702.49 | $52865.59 |
| Current liabilities | ||||
| Accounts payable | $8495.93 | $4587.47 | $4044.07 | $4133.6 |
| Deferred revenue | ||||
| Short long term debt | $1493.83 | $209.5 | $64.97 | |
| Total current liabilities | $12884.71 | $8179.78 | $8908.13 | $9084.94 |
| Long term debt | $359.52 | $1460.4 | $1488.21 | $1544.81 |
| Total noncurrent liabilities | $298.68 | $339.77 | $292.54 | |
| Total debt | ||||
| Total liabilities | $17715.99 | $14548.19 | $15442.16 | $14699.89 |
| Shareholders' equity | ||||
| Retained earnings | $44957.16 | $39607.82 | $36424.41 | $34792.32 |
| Other shareholder equity | $1182.74 | $2121.96 | $2166.62 | $1715.03 |
| Total shareholder equity | $47727.86 | $43317.64 | $40179.97 | $38096.25 |
| (in millions $) | 31 Jan 2023 | 29 Sep 2022 | 29 Jun 2022 | 1 May 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $24457.78 | $26432.1 | ||
| Cost of revenue | $21189.73 | $20518.5 | ||
| Gross Profit | $3268.05 | $5913.6 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2114.22 | $2123.3 | ||
| Total operating expenses | $23326.56 | $22601.1 | ||
| Operating income | $1131.22 | $3831 | ||
| Income from continuing operations | ||||
| EBIT | $1131.22 | $3831 | ||
| Income tax expense | $285.34 | $1054.1 | ||
| Interest expense | -$91.47 | -$175.8 | ||
| Net income | ||||
| Net income | $972.05 | $2944.1 | ||
| Income (for common shares) | $972.05 | $2944.1 | ||
| (in millions $) | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 | 30 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $81699.07 | $68792 | $61655.25 | $61052.09 |
| Cost of revenue | $68147.91 | $57707.57 | $51557.35 | $51422.38 |
| Gross Profit | $13551.16 | $11084.44 | $10097.89 | $9629.72 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $7302.92 | $6420.4 | $6116.62 | $6024.41 |
| Total operating expenses | $75678.35 | $64568.39 | $57690.91 | $57314.76 |
| Operating income | $6020.72 | $4223.61 | $3964.34 | $3737.34 |
| Income from continuing operations | ||||
| EBIT | $6020.72 | $4223.61 | $3964.34 | $3737.34 |
| Income tax expense | $1782.23 | $1211.61 | $1124.98 | $1154.98 |
| Interest expense | -$275.8 | -$212.81 | -$288.62 | -$185.91 |
| Net income | ||||
| Net income | $5069.08 | $3935.67 | $3219.93 | $3349.97 |
| Income (for common shares) | $5069.08 | $3935.67 | $3219.93 | $3349.97 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $972.05 | $2944.1 | $2156.62 | $648.2 |
| Operating activities | ||||
| Depreciation | $253.82 | $209.02 | $547.28 | $471.26 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $52 | $2739.8 | $1142.9 | $1663.66 |
| Investing activities | ||||
| Capital expenditures | -$1046.05 | -$993.66 | -$915.24 | -$1249.9 |
| Investments | ||||
| Total cash flows from investing | -$766.85 | -$887.04 | -$1621.36 | -$1034.48 |
| Financing activities | ||||
| Dividends paid | -$557.18 | -$425.8 | ||
| Sale and purchase of stock | ||||
| Net borrowings | $1343.63 | $575.79 | $5.61 | $85.9 |
| Total cash flows from financing | $627.55 | -$1472.54 | -$128.96 | $1.78 |
| Effect of exchange rate | -$0.84 | -$14.35 | $14.35 | -$11.9 |
| Change in cash and equivalents | -$88.14 | $365.78 | -$593.08 | $619.06 |
| (in millions $) | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 | 30 Dec 2018 |
|---|---|---|---|---|
| Net income | $5069.08 | $3935.67 | $3219.93 | $3349.97 |
| Operating activities | ||||
| Depreciation | $1829.56 | $2042.9 | $1589.25 | $1226.92 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $6012.44 | $5817.6 | $3275.35 | $3505.84 |
| Investing activities | ||||
| Capital expenditures | -$3501.01 | -$2346.41 | -$2199.6 | -$1977.57 |
| Investments | -$1453.99 | $48.02 | $577.77 | |
| Total cash flows from investing | -$2663.61 | -$3097.19 | -$938.64 | -$317.81 |
| Financing activities | ||||
| Dividends paid | -$851.6 | -$791.74 | -$840 | -$852 |
| Sale and purchase of stock | ||||
| Net borrowings | -$756.55 | -$3118.23 | -$294.37 | -$217.67 |
| Total cash flows from financing | -$1924.07 | -$4206.4 | -$1467.95 | -$1407.53 |
| Effect of exchange rate | $39.95 | $109.6 | -$107.84 | $33.15 |
| Change in cash and equivalents | $1464.7 | -$1376.39 | $760.92 | $1813.63 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.37 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |